Africa Regulatory Taskforce (ART)

Last Updated 20 October 2021.

3 Vaccines Approved for Use by ART

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 75 countries

  13 trials in 16 countries

  Approval Source: africacdc.org

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 124 countries

  45 trials in 23 countries

  Approval Source: africacdc.org

  Non Replicating Viral Vector

• Serum Institute of India
  Covishield (Oxford/AstraZeneca formulation)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 46 countries

  2 trials in 1 country

  Approval Source: africacdc.org

  Non Replicating Viral Vector